Cargando…

The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms

Fibroblast growth factor 21 (FGF21), is an emerging metabolic regulator mediates multiple beneficial effects in the treatment of metabolic disorders and related complications. Recent studies showed that FGF21 acts as an important inhibitor in the onset and progression of cardiovascular complications...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Mengjie, Tang, Yufeng, Wang, Shudong, Wang, Jie, Guo, Yuanfang, Zhang, Jingjing, Gu, Junlian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326758/ https://www.ncbi.nlm.nih.gov/pubmed/34349728 http://dx.doi.org/10.3389/fendo.2021.598008

Ejemplares similares

NRF2-Related Epigenetic Modifications in Cardiac and Vascular Complications of Diabetes Mellitus
por: Wang, Jie, et al.
Publicado: (2021)

Epigenetic Regulation Associated With Sirtuin 1 in Complications of Diabetes Mellitus
por: Wang(a), Jie, et al.
Publicado: (2021)

Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1/LKB1/AMPK pathway
por: Wang, Shudong, et al.
Publicado: (2017)

Fibroblast growth factor 21 and prognosis of patients with cardiovascular disease: A meta-analysis
por: Yan, Bing, et al.
Publicado: (2023)

Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2
por: Wang(a), Jie, et al.
Publicado: (2022)

Fibroblast growth factor 21 in metabolic syndrome
por: Yang, Ming, et al.
Publicado: (2023)

Circulating Fibroblast Growth Factor 21 and Total Testosterone in Type 2 Diabetes Mellitus Men With Coronary Heart Disease
por: Mei, Yufeng, et al.
Publicado: (2022)

Fibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders
por: Zhang, Jun, et al.
Publicado: (2015)

Adapting to the Cold: A Role for Endogenous Fibroblast Growth Factor 21 in Thermoregulation?
por: Klein Hazebroek, Marlou, et al.
Publicado: (2020)

Independent Association of Serum Fibroblast Growth Factor 21 Levels With Impaired Liver Enzymes in Hyperthyroid Patients
por: Xiao, Fangsen, et al.
Publicado: (2019)

Fibroblast Growth Factor 21-Null Mice Do Not Exhibit an Impaired Response to Fasting
por: Antonellis, Patrick Joseph, et al.
Publicado: (2016)

p53 at the Crossroads between Doxorubicin-Induced Cardiotoxicity and Resistance: A Nutritional Balancing Act
por: Guo, Yuanfang, et al.
Publicado: (2023)

Bifidobacterium adolescentis Alleviates Liver Steatosis and Steatohepatitis by Increasing Fibroblast Growth Factor 21 Sensitivity
por: Long, Xiaoxue, et al.
Publicado: (2021)

Resveratrol and FGF1 Synergistically Ameliorates Doxorubicin-Induced Cardiotoxicity via Activation of SIRT1-NRF2 Pathway
por: Lu, Guangping, et al.
Publicado: (2022)

Fibroblast Growth Factor 19 in Gestational Diabetes Mellitus and Fetal Growth
por: Yang, Meng-Nan, et al.
Publicado: (2022)

Fibroblast Growth Factor-21 to Adiponectin Ratio: A Potential Biomarker to Monitor Liver Fat in Children With Obesity
por: Tas, Emir, et al.
Publicado: (2020)

Fibroblast Growth Factor 21 Levels Exhibit the Association With Renal Outcomes in Subjects With Type 2 Diabetes Mellitus
por: Chang, Li-Hsin, et al.
Publicado: (2022)

A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity
por: Xiao, Mengjie, et al.
Publicado: (2021)

Resveratrol Attenuates High Glucose-Induced Osteoblast Dysfunction via AKT/GSK3β/FYN-Mediated NRF2 Activation
por: Xuan, Yue, et al.
Publicado: (2022)

Epigenetic Mechanisms Responsible for the Transgenerational Inheritance of Intrauterine Growth Restriction Phenotypes
por: Doan, Thu Ngoc Anh, et al.
Publicado: (2022)

SAT-046 Insulin-Like Growth Factor and Fibroblast Growth Factor 21 in Men with Klinefelter Syndrome
por: Chang, Simon, et al.
Publicado: (2020)

Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes
por: Khullar, Madhu, et al.
Publicado: (2017)

Plasma Levels of Myonectin But Not Myostatin or Fibroblast-Derived Growth Factor 21 Are Associated with Insulin Resistance in Adult Humans without Diabetes Mellitus
por: Toloza, Freddy J. K., et al.
Publicado: (2018)

Basic Fibroblast Growth Factor Predicts Cardiovascular Disease Occurrence in Participants from the Veterans Affairs Diabetes Trial
por: Zimering, Mark B., et al.
Publicado: (2013)

Fibroblast growth factor-23 and cardiovascular disease among prevalent hemodialysis patients focusing on residual kidney function
por: Kee, Youn Kyung, et al.
Publicado: (2023)

SAT-255 Evaluation of Uncoupling Protein 1 and Fibroblast Growth Factor 21 in Obese Adolescents
por: Pamuk, Gizem, et al.
Publicado: (2019)

Spinal Cord Injury Reduces Serum Levels of Fibroblast Growth Factor-21 and Impairs Its Signaling Pathways in Liver and Adipose Tissue in Mice
por: Liu, Xin-Hua, et al.
Publicado: (2021)

The transcriptomic and epigenetic alterations in type 2 diabetes mellitus patients of Chinese Tibetan and Han populations
por: Wang, Xian, et al.
Publicado: (2023)

Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment
por: Zhu, Yifei, et al.
Publicado: (2022)

Fibroblast Growth Factor Signaling in Metabolic Regulation
por: Nies, Vera J. M., et al.
Publicado: (2016)

Physiological Actions of Fibroblast Growth Factor-23
por: Erben, Reinhold G.
Publicado: (2018)

Upstream Regulators of Fibroblast Growth Factor 23
por: Ratsma, Danielle M. A., et al.
Publicado: (2021)

Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links
por: De Rosa, Salvatore, et al.
Publicado: (2018)

Molecular Mechanisms of Glucose Fluctuations on Diabetic Complications
por: Zhang, Zhen-Ye, et al.
Publicado: (2019)

Fibroblast Growth Factor 1 Promotes Rat Stem Leydig Cell Development
por: Chen, Lanlan, et al.
Publicado: (2019)

Circadian rhythm of plasminogen activator inhibitor-1 and cardiovascular complications in type 2 diabetes
por: Yu, Yongzhuo, et al.
Publicado: (2023)

Co-Treatment With Resveratrol and FGF1 Protects Against Acute Liver Toxicity After Doxorubicin Treatment via the AMPK/NRF2 Pathway
por: Xu, Xianchou, et al.
Publicado: (2022)

Role of Fibroblast Growth Factor-23 in Innate Immune Responses
por: Fitzpatrick, Elizabeth A., et al.
Publicado: (2018)

Direct and indirect effects of fibroblast growth factor 23 on the heart
por: Nakano, Toshiaki, et al.
Publicado: (2023)

Fibroblast Growth Factor 19 Levels Predict Subclinical Atherosclerosis in Men With Type 2 Diabetes
por: Hu, Jingyi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_elqqe3q3ak580tjhllpbumg6gk